Related Experiment Video
Updated: Jan 27, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion
U-Ging Lo1, Jiming Bao2, Junjie Cen3
1Department of Urology, University of Texas Southwestern Medical Center Dallas, TX 75390, USA.
Abstract:
Interferon is known as a pleiotropic factor in innate immunity, cancer immunity and therapy. Despite an objective short-term response of interferon (IFN) therapy in renal cell carcinoma (RCC) patients, the potential adverse effect of IFN on RCC cells is not fully understood. In this study, we demonstrate that IFNs can enhance RCC invasion via a new mechanism of IFIT5-mediated tumor suppressor microRNA (miRNA) degradation resulted in the elevation of Slug and ZEB1 and epithelial-to-mesenchymal transition (EMT). Clinically, a significant upregulation of IFNγ signaling pathway (such as IFNGR1, IFNGR2, STAT1 and STAT2) is observed in RCC patients with metastatic disease. Overall, this study provides a new mechanism of action of IFN-elicited canonical pathway in regulating suppressor miRNAs. Most importantly, it highlights the potential pro-metastatic effect of IFNs, which could undermine the clinical applicability of IFNs for treating RCC patients.
Insights
Interferon therapy may unexpectedly promote renal cell carcinoma (RCC) invasion by degrading tumor suppressor microRNAs, potentially hindering its clinical use. This study reveals a new pro-metastatic mechanism involving IFIT5 and epithelial-to-mesenchymal transition (EMT).
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interferon (IFN) is a key factor in immunity and cancer therapy.
- IFN therapy shows short-term response in renal cell carcinoma (RCC) but its adverse effects on RCC cells are unclear.
Purpose of the Study:
- To investigate the potential adverse effects of IFNs on RCC cells.
- To elucidate the mechanism by which IFNs might enhance RCC invasion.
Main Methods:
- Investigated the role of IFIT5 in microRNA (miRNA) degradation.
- Assessed the impact of IFN on Slug, ZEB1, and epithelial-to-mesenchymal transition (EMT) in RCC cells.
- Analyzed IFNγ signaling pathway in metastatic RCC patient samples.
Main Results:
- IFNs enhance RCC invasion through IFIT5-mediated degradation of tumor suppressor miRNAs.
- This degradation leads to increased Slug and ZEB1 expression, promoting EMT.
- Upregulation of IFNγ signaling pathway components (IFNGR1, IFNGR2, STAT1, STAT2) correlates with metastatic RCC.
Conclusions:
- IFNs can promote RCC metastasis via a novel mechanism involving suppressor miRNA degradation.
- This finding highlights a potential pro-metastatic effect of IFNs that may limit their use in RCC treatment.
Related Concept Videos
Properties of Transition Metals
Cooperative Allosteric Transitions
Phase Transitions
The Eukaryotic Promoter Region
Phase Transitions: Vaporization and Condensation
Phase Transitions: Sublimation and Deposition

